PHARMACEUTICAL MARKET INDIA 2014-2020

2,800.008,000.00

Published August 2014

PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 333 tables & figures.

Download Free sample pages here

Clear

Description

Click here for free sample pages

PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 333 tables & figures. The Indian pharmaceutical market (IPM) is presented as follows:

 

  • By Company (e.g., CIPLA, SUN PHARMA, RANBAXY, PIRAMAL, ZYDUS CADILA, MANKIND, LUPIN)
  • By Segment (FORMULATIONs, APIs, BIOSIMILARs, CRAMS, GENERICS, VACCINES)
  • By Therapeutic Area (e.g., Cardiovascular, Diabetes, Cancer, Respiratory)
  • By Disease Category (Acute, Chronic)

 

A wealth of financial information is provided including:

 

  • Up-to-date company financials, sales & revenue figures
  • India GDP, economic growth, export (bulk drug, formulations) figures
  • Indian health expenditure as a function of GDP
  • Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
  • Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)

 

SWOT, Economic and Business Environment specifics include:

 

  • Key strengths, weaknesses and threats influencing leading player position within the IPM
  • Top five fastest growing Indian pharma market segments
  • Top five emerging opportunities within the IPM
  • Top pharmaceutical companies within the IPM by market share and revenue
  • Multinational penetration into the Indian Pharma Market
  • Comprehensive product portfolios, R&D activity and pipeline therapeutics
  • M&A activity and future strategies of top Indian pharmacos
  • Economic indicators, trade policy, merchandise and commercial trade statistics
  • Gross Domestic Product of India, historic and projection analysis
  • Indian economic outlook in comparison to advanced economies

 

This report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy.

 

  • Aurobindo Pharma
  • Bharat Serums and Vaccines Ltd
  • Biocon Biopharmaceuticals
  • Cipla
  • Divis Laboratories
  • Dr Reddy’s Laboratories
  • Lupin
  • Mankind Pharma
  • Panacea Biotech
  • Piramal Group
  • Ranbaxy Laboratories
  • Reliance Life Sciences
  • Serum Institute of India
  • Sun Pharmaceuticals
  • Zydus Cadila

 

Forecast projections and future growth rates are provided to give you a forthcoming perspective of this growing industry. Current developments relating to patent expirations, government funding, and regulations are discussed.  The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.

 

What you will gain:

 

  • An in-depth understanding of the Indian biopharmaceutical market and it’s environment
  • Current market facts, figures and product lines of key players in the industry
  • An insight into how generic therapeutics will propagate the Indian biopharmaceutical market
  • Knowledge of how the Indian biopharma market will integrate into the global healthcare market
  • Information on key government policies
  • Strategies on how to adapt and restructure current business models to this industry
  • Clients may also use referenced tables, figures and data for their own reports and presentations

 

This report will tell you if the companies mentioned are:

  • Strong, competitive players
  • Pooling their resources for specific growth and therapeutic areas
  • Investing strategically in R&D
  • Have a history of strategic M&A activity

 

The Pharmaceutical Market India report also provides you with a comprehensive company directory of key people and contact details.

Additional information

Licence Types

, ,

Reviews

There are no reviews yet.

Be the first to review “PHARMACEUTICAL MARKET INDIA 2014-2020”